Keyphrases
Older Adults
100%
Treatment Burden
100%
Newly Diagnosed multiple Myeloma
100%
First Year
45%
Adjusted Odds Ratio
36%
Multiple Myeloma
27%
Newly Diagnosed
18%
Surveillance Epidemiology
18%
Tailored Intervention
18%
Substantial Burden
18%
Linked Database
18%
Hematological Malignancies
9%
Comorbidity
9%
Logistic Regression
9%
Medicare
9%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
9%
Charlson Comorbidity Index
9%
Myeloma
9%
Bone Disease
9%
Provided Support
9%
Poor Performance Status
9%
Healthcare
9%
Oncology
9%
Physician Visits
9%
Acute Care
9%
Treatment Advances
9%
Patient-centered Care
9%
End-organ Damage
9%
Care Relationship
9%
Outpatient Visits
9%
Non-oncology
9%
Medicine and Dentistry
Multiple Myeloma
100%
Odds Ratio
80%
Health Care
40%
Hematologic Malignancy
20%
Patient Care
20%
Medicare
20%
Logistic Regression Analysis
20%
Cohort Effect
20%
Surveillance, Epidemiology, and End Results
20%
Charlson Comorbidity Index
20%
Oncology
20%
Outpatient
20%
Autologous Stem Cell Transplantation
20%
Emergency Care
20%
Myeloma
20%
End Organ Damage
20%
Comorbidity
20%
Bone Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Comorbidity
40%
Hematologic Malignancy
20%
Myeloma
20%
Bone Disease
20%